title: Why are we using pulse oximetry but not neuromuscular monitoring routinely: the real world scenario?
authors.affiliation: Department of Anesthesiology and Pain Medicine, Martini General Hospital Groningen, Groningen, the Netherlands, hd.de.boer@mzh.nl Department of Anesthesiology and Pain Medicine, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands.
authors.forename: Hans D
authors.initials: HD
authors.lastname: de Boer
authors.forename: Leo Hdj
authors.initials: LH
authors.lastname: Booij
mesh_terms: D000732:Androstanols / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D018908:Muscle Weakness / Q000517:prevention & control*; D009388:Neostigmine / Q000627:therapeutic use*; D019148:Neuromuscular Blockade / Q000379:methods*; D009469:Neuromuscular Junction / Q000187:drug effects*; D061886:Neuromuscular Monitoring; D003473:Neuromuscular Nondepolarizing Agents / Q000627:therapeutic use*; D047408:gamma-Cyclodextrins / Q000627:therapeutic use*
chemical_list: D000732:Androstanols; D002800:Cholinesterase Inhibitors; D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins; D009388:Neostigmine